Coronavirus disease 2019 (COVID-19) is a novel infectious disease with lack of established laboratory markers available to evaluate illness severity. In this study, we investigate whether platelet count could differentiate between COVID-19 patients with or without severe disease. Additionally, we evaluate if thrombocytopenia is associated with severe COVID-19
Hemostatic abnormalities had been reported in COVID-19 patients, which may include disseminated intr...
: SARS-CoV-2 infection may cause a wide spectrum of symptoms, from asymptomatic, to mild respiratory...
BackgroundThrombocytopenia has been proved to be associated with hospital mortality in patients with...
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a novel infectious disease with lack of establish...
The 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-...
Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory Syndrome Coronavir...
Background: Covid- 19 infection has caused global pandemic. One of the important pathogenic mechanis...
(1) Background: Hospital mortality in patients suffering from SARS-CoV-2 infection has been associat...
Abstract Background and Aims Thrombocytopenia is increasingly recognized among patients with critica...
COVID-19 is known to cause serious respiratory symptoms and involvement of other body systems such a...
© 2021 International Society on Thrombosis and Haemostasis Objective: Heightened inflammation, dysre...
Covid-19 has emerged as a global threat that has claimed millions of lives until now. Haematological...
ObjectiveHeightened inflammation, dysregulated immunity, and thrombotic events are characteristic of...
The coronavirus disease 2019 (COVID-19) is a contagious respiratory tract infection caused by the be...
none5noHere, we describe three cases of immune-mediated thrombocytopenia during the severe acute res...
Hemostatic abnormalities had been reported in COVID-19 patients, which may include disseminated intr...
: SARS-CoV-2 infection may cause a wide spectrum of symptoms, from asymptomatic, to mild respiratory...
BackgroundThrombocytopenia has been proved to be associated with hospital mortality in patients with...
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a novel infectious disease with lack of establish...
The 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-...
Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory Syndrome Coronavir...
Background: Covid- 19 infection has caused global pandemic. One of the important pathogenic mechanis...
(1) Background: Hospital mortality in patients suffering from SARS-CoV-2 infection has been associat...
Abstract Background and Aims Thrombocytopenia is increasingly recognized among patients with critica...
COVID-19 is known to cause serious respiratory symptoms and involvement of other body systems such a...
© 2021 International Society on Thrombosis and Haemostasis Objective: Heightened inflammation, dysre...
Covid-19 has emerged as a global threat that has claimed millions of lives until now. Haematological...
ObjectiveHeightened inflammation, dysregulated immunity, and thrombotic events are characteristic of...
The coronavirus disease 2019 (COVID-19) is a contagious respiratory tract infection caused by the be...
none5noHere, we describe three cases of immune-mediated thrombocytopenia during the severe acute res...
Hemostatic abnormalities had been reported in COVID-19 patients, which may include disseminated intr...
: SARS-CoV-2 infection may cause a wide spectrum of symptoms, from asymptomatic, to mild respiratory...
BackgroundThrombocytopenia has been proved to be associated with hospital mortality in patients with...